CNSP - CIK 0001729427
CNS Pharmaceuticals, Inc. has filed 379 documents with the SEC between 2018 and 2026. The most frequent type is major company event (98 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Filing | Type | Filed | Period covered |
|---|---|---|---|
| Annual report (amended) | 10-K/A | 2025-04-30 | 2024-12-31 |
| Company correspondence | CORRESP | 2025-04-17 | - |
| Company correspondence | CORRESP | 2025-04-17 | - |
| Company correspondence | CORRESP | 2025-04-14 | - |
| Company correspondence | CORRESP | 2025-04-14 | - |
| IPO registration | S-1 | 2025-04-14 | - |
| SEC correspondence | UPLOAD | 2025-04-11 | - |
| Major company event | 8-K | 2025-04-09 | 2025-04-09 |
| DRSLTR | - | 2025-04-07 | - |
| DRS | - | 2025-04-07 | - |
| Major company event | 8-K | 2025-03-31 | 2025-03-31 |
| Annual report | 10-K | 2025-03-31 | 2024-12-31 |
| Prospectus supplement | 424B5 | 2025-03-20 | - |
| Major company event | 8-K | 2025-03-20 | 2025-03-20 |
| Major company event | 8-K | 2025-02-21 | 2025-02-19 |
| Major company event | 8-K | 2025-01-03 | 2025-01-03 |
| Major company event | 8-K | 2024-12-11 | 2024-12-11 |
| Major company event | 8-K | 2024-12-03 | 2024-11-26 |
| DEFR14A | - | 2024-11-15 | - |
| Quarterly report | 10-Q | 2024-11-14 | 2024-09-30 |
| Passive ownership stake (update) | SC 13G/A | 2024-11-14 | - |
| Major company event | 8-K | 2024-11-01 | 2024-10-30 |
| Proxy statement | DEF 14A | 2024-10-28 | 2024-11-26 |
| Major company event | 8-K | 2024-10-24 | 2024-10-23 |
| Prospectus supplement | 424B5 | 2024-10-24 | - |
| Major company event | 8-K | 2024-10-23 | 2024-10-23 |
| PRE 14A | - | 2024-10-15 | 2024-11-26 |
| Major company event | 8-K | 2024-09-18 | 2024-09-12 |
| Major company event | 8-K | 2024-09-12 | 2024-09-10 |
| Quarterly report | 10-Q | 2024-08-14 | 2024-06-30 |
| Major company event | 8-K | 2024-08-07 | 2024-08-06 |
| Insider trade | 4 | 2024-08-06 | 2024-07-30 |
| New insider ownership | 3 | 2024-08-06 | 2024-07-29 |
| EFFECT | - | 2024-08-02 | - |
| Activist ownership stake | SC 13D | 2024-08-02 | - |
| RW | - | 2024-07-31 | - |
| 424B3 | - | 2024-07-30 | - |
| Major company event | 8-K | 2024-07-30 | 2024-07-30 |
| Major company event | 8-K | 2024-07-30 | 2024-07-29 |
| Prospectus supplement | 424B5 | 2024-07-26 | - |
| Major company event | 8-K | 2024-07-26 | 2024-07-26 |
| Major company event | 8-K | 2024-07-24 | 2024-07-19 |
| S-1/A | - | 2024-07-19 | - |
| IPO registration | S-1 | 2024-07-12 | - |
| Major company event (amended) | 8-K/A | 2024-07-12 | 2024-07-05 |
| Major company event | 8-K | 2024-07-09 | 2024-07-05 |
| Prospectus supplement | 424B5 | 2024-07-05 | - |
| Major company event | 8-K | 2024-07-03 | 2024-07-03 |
| Passive ownership stake | SC 13G | 2024-07-02 | - |
| Prospectus supplement | 424B5 | 2024-06-27 | - |